— Know what they know.
Not Investment Advice
Also trades as: OBSN.SW (SIX) · $vol 0M

OBSV NASDAQ

ObsEva S.A.
1W: -4.5% 1M: -17.5% 3M: -57.1% 1Y: -94.0% 3Y: -96.3%
$0.10
Last traded 2023-04-24 — delisted
NASDAQ · Healthcare · Biotechnology · $11.0M mcap · 94M float · 8.50% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Income Trends

Revenue
$20M +0.0% ▲
Gross Profit
$20M +0.0% ▲
Operating Income
-$16M +71.2% ▲
Net Income
-$30M +48.8% ▲
EPS (Diluted)
$-0.32 +59.0% ▲
EBITDA
-$20M +71.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$0$0$0$0$20M
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$0
Gross Profit$0$0$0$0$20M
Gross Margin————100.0%
R&D Expenses$63M$88M$68M$53M$11M
SG&A Expenses$14M$19M$12M$21M$25M
Operating Expenses$77M$107M$80M$55M$35M
Operating Income-$77M-$107M-$80M-$55M-$16M
Operating Margin————-79.8%
Interest Expense$0$2M$4M$3M$9M
Income Before Tax-$77M-$109M-$83M-$58M-$30M
Tax Expense-$45K$67K$34K$212K$11K
Net Income-$77M-$109M-$83M-$58M-$30M
Net Margin————-152.2%
EPS (Diluted)$-1.91$-2.49$-1.67$-0.78$-0.32
EBITDA-$77M-$106M-$78M-$71M-$20M
Shares Outstanding40M44M50M75M92M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms